Quince Therapeutics, Inc. (QNCX)
USD 1.85
(0.54%)
USD 1.85
(0.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 322 Thousand | 175 Thousand | 344 Thousand | 332 Thousand | 188 Thousand | 51 Thousand |
| Gross Profit | -322 Thousand | -175 Thousand | -344 Thousand | -332 Thousand | -188 Thousand | -51 Thousand |
| Operating Expenses | 34.62 Million | 51.19 Million | 90.31 Million | 78.89 Million | 39.16 Million | 12.11 Million |
| Selling, General and Administrative Expenses | 17.69 Million | 26.01 Million | 29.52 Million | 17.58 Million | 8.95 Million | 2.03 Million |
| Research and Development Expenses | 9.44 Million | 25.17 Million | 60.79 Million | 61.3 Million | 30.21 Million | 10.08 Million |
| Other Expenses | 7.47 Million | -997 Thousand | -247 Thousand | - | - | - |
| Cost and Expenses | 34.62 Million | 51.19 Million | 90.31 Million | 78.89 Million | 39.16 Million | 12.11 Million |
| Operating Income | -34.62 Million | -52.01 Million | -90.31 Million | -78.89 Million | -39.16 Million | -12.11 Million |
| Interest Expense | - | 568 Thousand | - | - | - | 957 Thousand |
| Income Tax Expense | -197 Thousand | -284 Thousand | -620 Thousand | 2.16 Million | -188 Thousand | 357 Thousand |
| Earnings before Tax | -31.58 Million | -51.94 Million | -89.94 Million | -76.84 Million | -36.98 Million | -12.47 Million |
| Net Income | -31.38 Million | -51.66 Million | -89.32 Million | -76.84 Million | -36.79 Million | -12.47 Million |
| Earnings Per Share Basic | -0.84 | -1.54 | -3.01 | -2.63 | -1.93 | -0.58 |
| Earnings Per Share Diluted | -0.84 | -1.54 | -3.01 | -2.63 | -1.93 | -0.58 |
| Weighted Average Shares Outstanding | 37.23 Million | 33.49 Million | 29.71 Million | 29.17 Million | 19.03 Million | 21.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.23 Million | 33.49 Million | 29.71 Million | 29.17 Million | 19.03 Million | 21.55 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -31.26 Million | -52.01 Million | -89.97 Million | -78.56 Million | -38.98 Million | -12.06 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 36 Thousand | - | - |
| Cost of Revenue | 44 Thousand | 40 Thousand | 322 Thousand | 304 Thousand | - | 1000.00 |
| Gross Profit | -44 Thousand | -40 Thousand | -322 Thousand | -268 Thousand | - | -1000.00 |
| Operating Expenses | 8.79 Million | 6.13 Million | 24.32 Million | 8.03 Million | 6.09 Million | 5.58 Million |
| Selling, General and Administrative Expenses | 4.65 Million | 2.63 Million | - | 4.6 Million | 4.66 Million | 4.23 Million |
| Research and Development Expenses | 4.14 Million | 3.5 Million | - | 3.43 Million | 1.43 Million | 1.35 Million |
| Other Expenses | -324 Thousand | -787 Thousand | 7.47 Million | 64 Thousand | -216 Thousand | -107 Thousand |
| Cost and Expenses | 8.84 Million | 6.17 Million | 24.64 Million | 8.34 Million | 6.09 Million | 5.58 Million |
| Operating Income | -8.84 Million | -6.17 Million | -24.64 Million | -8.34 Million | -6.09 Million | -5.58 Million |
| Interest Expense | - | - | - | 454 Thousand | - | - |
| Income Tax Expense | 36 Thousand | 31 Thousand | -197 Thousand | 51 Thousand | -919.41 Thousand | -805 Thousand |
| Earnings before Tax | -27.69 Million | -11.11 Million | -31.58 Million | -8.84 Million | -5.35 Million | -4.88 Million |
| Net Income | -27.72 Million | -11.14 Million | -31.38 Million | -8.89 Million | -5.35 Million | -4.88 Million |
| Earnings Per Share Basic | -0.64 | -0.26 | - | -0.22 | -0.15 | -0.14 |
| Earnings Per Share Diluted | -0.64 | -0.26 | - | -0.22 | -0.15 | -0.14 |
| Weighted Average Shares Outstanding | 43.09 Million | 43.01 Million | 37.23 Million | 40.97 Million | 36.07 Million | 35.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.09 Million | 43.01 Million | 37.23 Million | 40.97 Million | 36.07 Million | 35.91 Million |
| Gross Margin | - | - | - | -7.44 | - | - |
| EBIT Margin | - | - | - | -223.31 | - | - |
| Profit Margin | - | - | - | -247.06 | - | - |
| EBITDA | -8.79 Million | -6.13 Million | - | -8.03 Million | -6.09 Million | -5.58 Million |
| Earnings Before Tax Margin | - | - | - | -231.75 | - | - |
USLG
PEIMF
RGLSF
ARH
QEC
CCLINTER